DHFR and acute lymphoblastic leukemia: One study reported a significant correlation between TP53 mutations and increased levels of DHFR mRNA in patients with acute lymphoblastic leukemia (ALL) (Goker et al., 1995), suggesting that the amplification of DHFR and TP53 mutations might be correlated with MTX resistance in ALL patients.